Assessment of Causes of Adverse Drug Reaction Underreporting in South of Iraq

Mohammed Mahdi H. Abdul Hussein; Jubran K. Hassan

Mohammed Mahdi H. Abdul Hussein Department of Clinical Pharmacy, College of Pharmacy, University of Basrah, Iraq
Jubran K. Hassan Department of Clinical Pharmacy, College of Pharmacy, University of Basrah, Iraq

Keywords: Doctors, clinical pharmacists, and general pharmacists.

Abstract

Background: Pharmacy professionals, other healthcare professionals, and patients can all gain from a continuous adverse drug reaction tracking and reporting strategy. The purpose of pharmacovigilance procedures is to collect information on various aspects of the safety of pharmaceutical goods in general. Patient, healthcare professional, and manufacturer reports are the main sources of information on adverse events that arise spontaneously. Pharmacovigilance is a requirement for all healthcare practitioners, making pharmacists and doctors essential healthcare providers in responsibility of adverse drug reaction reporting throughout their practices and teaching the general public about pharmacovigilance. The current study sought to investigate and evaluate the main causes of ADR underreporting.

Methodology: Doctors, clinical pharmacists, and general pharmacists in the Basra governorate made up the study's sample. A total of (552) of the (900) healthcare providers who were the target of the study took part. Doctors made up 268 of the total participants (552), general pharmacists made up 225, and clinical pharmacists made up 59. This study, conducted in the Basra Governorate, covered 8 significant hospitals. A paper questionnaire was used in a randomly chosen observational cross-sectional study. All data were examined using IBM SPSS Statistic version 26.

Results: In terms of the overall participant count, there were significantly more females (65.6%) than males (34.4%). Statistics show that the proportion of HCPs with fewer than five years of work experience (64.6%) is higher than that of those with five or more years of experience (35.4%).

Lack of clinical expertise among healthcare professionals was the major reason of underreporting.

Conclusion: The most significant causes contributing to the fall in the degree of documentation or underreporting in health institutions are the absence of clinical expertise for the majority of health staff and the failure to get information from patients in an appropriate, correct, and precise way.

References

1. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255-59.
2. Formica D, Sultana J, Cutroneo PM, Lucchesi S, Angelica R, Crisafulli S, et al. The economic burden of preventable adverse drug reactions: a systematic review of observational studies. Vol. 17, Expert Opinion on Drug Safety. Taylor and Francis Ltd; 2018. p. 681–95.
3. SULAIMAN MG, MOHAMMAD FK, ALHASSANI AN. ADVERSE DRUG REACTIONS MONITORING: A PHARMACOVIGILANCE STUDY AT ERBIL AND DUHOK MAIN HOSPITALS IN KURDISTAN REGION / IRAQ. Duhok Medical Journal [Internet]. 2018
4. Montané E, Santesmases J. Adverse drug reactions Reacciones adversas a medicamentos. Vol. 154, Med Clin (Barc). 2020.
5. Lazarou J, Pomeranz BH, Corey PN. Incidence of Adverse Drug Reactions in Hospitalized Patients A Meta-analysis of Prospective Studies.
6. Bouvy JC, De Bruin ML, Koopmanschap MA. Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies. Vol. 38, Drug Safety. Springer International Publishing; 2015. p. 437–53.
7. Giardina C, Cutroneo PM, Mocciaro E, Russo GT, Mandraffino G, Basile G, et al. Adverse drug reactions in hospitalized patients: Results of the FORWARD (facilitation of reporting in hospital ward) study. Front Pharmacol. 2018 Apr 11;9(APR).
8. Vora MB, Trivedi HR, Shah BK, Tripathi CB. Adverse drug reactions in inpatients of internal medicine wards at a tertiary care hospital: A prospective cohort study. Vol. 2, Journal of Pharmacology and Pharmacotherapeutics. 2011. p. 21–5.
9. Chen RT, Rastogi SC, Mullen JR, Hayes SW, Cochi SL, Donlon JA, et al. The Vaccine Adverse Event Reporting System (VAERS). 1994.
10. Rawlins. College lectures Pharmacovigilance: paradise lost, regained or postponed?
11. Lindquist M. The Need for Definitions in Pharmacovigilance. Vol. 30, Drug Safety. 2007.
12. World Health Organization., WHO Collaborating Centre for International Drug Monitoring. The importance of pharmacovigilance. World Health Organization; 2002. 48 p.
13. Alshammari TM, Mendi N, Alenzi KA, Alsowaida Y. Pharmacovigilance Systems in Arab Countries: Overview of 22 Arab Countries. Vol. 42, Drug Safety. Springer International Publishing; 2019. p. 849–68.
14. Aziz Z, Siang TC, Badarudin NS. Reporting of adverse drug reactions: Predictors of under-reporting in Malaysia. Pharmacoepidemiol Drug Saf. 2007 Feb;16(2):223–8.
15. Hazell L, Shakir SAW. Under-Reporting of Adverse Drug Reactions A Systematic Review. Vol. 29, Drug Safety. 2006.
16. Shalini S, Mohan S. Knowledge and attitude towards pharmacovigilance and adverse drug reaction reporting among dental students in a Private University, Malaysia. Journal of Young Pharmacists. 2015 Apr 1;7(2):118–25.
17. RMS M, YA A. Physicians’ knowledge about pharmacovigilance in Iraq. J Pharmacovigil. 2016;4(3).
18. Al-Lela OQB. Adverse Drug Reactions (ADR’s) Reporting Barriers and Attitude among Pharmacists in Erbil, Kurdistan Region – Iraq [Internet]. 2017. Available from: https://www.researchgate.net/publication/328346065
19. Salih MuhannadRM, Abd A, Kurmanji J, Al-Lela OQ. Assessment of community pharmacists concerning pharmacovigilance in Iraq. Arch Pharm Pract. 2016;7(4):136.
20. Adheed Khalid Sharrad, Haydar F.AL-Tukmagi, Ghassan Salah Ahmed. Knowledge, Attitude and Practice towards Pharmacovigilance and Adverse Drug Reaction. Int J Pharm Sci Rev Res. 2017;83